Atnahs Pharma UK Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atnahs Pharma UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11495
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atnahs Pharma UK Ltd (Atnahs Pharma), a subsidiary of Waymade Plc, is a developer, manufacturer, supplier and distributor of pharmaceutical products. The company provides products such as anacal ointment; dermacort cream; dipentum; gygel, a spermicidal contraceptive, and among others. Atnahs has a pipeline of niche generic compounds in solid dose, liquid and sterile forms. The company outsources its production to contract manufacturing organizations (CMO) with specialized expertise. Atnahs has the capability to provide comprehensive product support to companies including regulatory, pharmacovigilance, finance, supply chain and logistics functions. The company has a global network of commercial partners. Atnahs Pharma is headquartered at Basildon, the UK.

Atnahs Pharma UK Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Atnahs Pharma Acquires Naprosyn, Anaprox and Toradol from Roche 10
Atnahs Pharma Acquires Rights to Dipentum from UCB Pharma 11
Licensing Agreements 12
Provepharm Enters Into Licensing Agreement With NordMedica 12
Acquisition 13
Atnahs Pharma Acquires Pharmanovia 13
Atnahs Pharma Acquires Marlborough Pharma, Huntley Pharma and Alphashow 14
Atnahs Pharma UK Ltd – Key Competitors 15
Atnahs Pharma UK Ltd – Key Employees 16
Atnahs Pharma UK Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atnahs Pharma UK Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atnahs Pharma Acquires Naprosyn, Anaprox and Toradol from Roche 10
Atnahs Pharma Acquires Rights to Dipentum from UCB Pharma 11
Provepharm Enters Into Licensing Agreement With NordMedica 12
Atnahs Pharma Acquires Pharmanovia 13
Atnahs Pharma Acquires Marlborough Pharma, Huntley Pharma and Alphashow 14
Atnahs Pharma UK Ltd, Key Competitors 15
Atnahs Pharma UK Ltd, Key Employees 16
Atnahs Pharma UK Ltd, Other Locations 17
Atnahs Pharma UK Ltd, Subsidiaries 17

List of Figures
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atnahs Pharma UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Atnahs Pharma UK Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zenkyoren:企業の戦略・SWOT・財務分析
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • JD Sports Fashion Plc:企業の戦略・SWOT・財務情報
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Companhia Riograndense de Mineracao:企業の戦略・SWOT・財務情報
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • DecImmune Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DecImmune Therapeutics Inc (DecImmune) is a pharmaceutical research company. The company develops a humanised antibody, which is used in preventing tissue damage and block inflammation caused from vascular injuries. It conducts research and development on N2, an innate IgM-mediated auto-immu …
  • Allied Irish Banks, Plc:企業のM&A・事業提携・投資動向
    Allied Irish Banks, Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Irish Banks, Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Cisco Systems, Inc (CSCO)-エネルギー分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Xi’An Catering Co., Ltd.
    Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology …
  • Doosan Heavy Industries & Construction Co Ltd (034020):企業の財務・戦略的SWOT分析
    Doosan Heavy Industries & Construction Co Ltd (034020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • JEA:発電所・企業SWOT分析
    JEA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Pharmerica Corp:企業の戦略的SWOT分析
    Pharmerica Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Konami Holdings Corp:企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Marshall of Cambridge (Holdings) Ltd:企業の戦略的SWOT分析
    Marshall of Cambridge (Holdings) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆